TITLE
Comprehensive Approaches to Addressing Atopic Dermatitis in Very Young Patients


PROVIDERSHIP

This educational activity is provided by Albert Einstein College of Medicine-Montefiore Medical Center and RealCME


ACKNOWLEDGEMENT OF FINANCIAL SUPPORT
This activity is supported by an independent educational grant from Sanofi and Regeneron Pharmaceuticals.

Release Date: January 4, 2024

Expiration Date: January 25, 2025

Estimated time to complete this activity: 4 hours and 30 minutes


STATEMENT OF NEED

Pediatric atopic dermatitis (AD) is a chronic and inflammatory skin disease commonly observed in children; it typically presents before the age of 5 in the majority of children. AD has a significant negative impact on the quality of life of both the affected child and their parents, caregivers, and family members. It impacts developmental variables such as sleep and relationships and can impose a significant financial burden on families. Caring for children with AD can be extremely time-consuming and may lead to work absenteeism or reduced productivity for caregivers. Additionally, the treatment burden can be high, requiring the adoption of special diets, strategies to avoid irritants and allergens, and the use of multi-step skin care and medication treatment regimens.

Diagnosing AD can be challenging due to its diverse presentation and an extensive list of differential diagnoses. To facilitate diagnosis, the American Academy of Dermatology (AAD) has developed criteria that highlight essential features like pruritus, supportive features such as early age at onset, and associated features that suggest the diagnosis, such as lichenification.

Treatment options for AD in children include emollients, topical corticosteroids, topical calcineurin inhibitors, PDE4 inhibitors, systemic oral and injectable treatments, and phototherapy. Current guidelines recommend systemic therapy for children with moderate to severe AD who do not achieve sufficient disease control with topical therapy and/or phototherapy. However, there are limited approved options for systemic immunomodulators in these children, with systemic corticosteroids having numerous adverse effects, and a single approved biologic for those children 6 months or older in the US.

EDUCATIONAL OBJECTIVES

• Acquire skills in managing pediatric atopic dermatitis (AD), demonstrating accuracy in assessment, use of evidence-based diagnostic tools, and appropriate referral processes.
• Integrate knowledge of efficacy and safety data related to the use of biologics in children ages 6 months to 5 years with moderate-to-severe AD into daily practice.
• Apply the latest expert recommendations, including regarding the use of biologics, for treating moderate-to-severe atopic dermatitis (AD) in children aged 6 months to 5 years.

TARGET AUDIENCE
This educational initiative is designed for pediatric and family medicine clinicians (MDs, DOs, APPs).


ACCREDITATION STATEMENT

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and RealCME, LLC. Albert Einstein College of Medicine-Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


CREDIT DESIGNATION STATEMENT
Albert Einstein College of Medicine-Montefiore Medical Center designates this other activity (blended live and enduring curriculum) for a maximum of 4.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Credits

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 4.5 hours of Category 1 credit for completing this program.

American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) Program

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.50 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


DISCLOSURE OF FINANCIAL RELATIONSHIPS
The “Policy on Identification, Mitigation, and Disclosure of Relevant Financial Relationships” of Albert Einstein College of Medicine-Montefiore Medical Center requires that any individual in control of content, including faculty, participating in CME activities disclose to the audience all relevant financial relationships with ineligible companies* in the past 24 months. Any individual in control of content who refuses to disclose, or whose disclosed relationships prove to create a conflict of interest, will be recused.

Individuals with the absence of relevant financial relationships with ineligible companies will be disclosed to the audience.

All financial relationships of individuals in a position to control the content of this CME activity are identified and mitigated prior to the educational activity.

*The ACCME defines an ineligible company as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


DISCLOSURE OF UNLABELED USE
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient’s medical condition.


ACCREDITED PROVIDER DISCLOSURE
The planners, and the Albert Einstein College of Medicine-Montefiore Medical Center staff for this educational activity have disclosed no relevant financial relationship(s) with an ACCME-defined ineligible company in the last 24 months.

FACULTY CO-CHAIRS 

Markus Boos, MD, PhD
Associate Professor of Pediatrics
Department of Dermatology 
Seattle Children’s - Dermatology
Seattle, WA

Dr. Boos has disclosed that he has no relevant financial relationships with an ACCME-defined ineligible company in the last 24 months.

Lacey L. Kruse, MD
Associate Professor of Pediatrics, Dermatology 
Attending Physician, Dermatology
Northwestern University Feinberg School of Medicine 
Chicago, IL

Dr. Kruse has disclosed that she has no relevant financial relationships with an ACCME-defined ineligible company in the last 24 months.

Julia K. Gittler, MD (Peer Reviewer)
Assistant Professor, Department of Medicine (Dermatology)
Assistant Professor, Department of Pediatrics
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Dr. Gittler has disclosed that she has no relevant financial relationships with an ACCME-defined ineligible company in the last 24 months.

METHOD OF PARTICIPATION/INSTRUCTIONS ON HOW TO RECEIVE CREDIT
To obtain credit, a score of 70% or better on the Final Assessment is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this curriculum, answered all test questions, completed the Final Assessment, Post Group Assessment, and evaluation, and have received a digital copy of your credit certificate.

• Three Self-Assessments: 1.0 hour of CME
• Two Self-study modules: 15 minutes each for a total of 0.50 hour of CME
• Two Live Group Discussions: 45 minutes each for a total of 1.5 hours of CME
• Three Group Challenges: 30 minutes each for a total of 1.5 hours of CME  (includes Action Plan development)

If you are seeking credit, you must complete the assessment and evaluation at the conclusion of the activity. Your certificate can be printed immediately.


DISCLAIMER
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine-Montefiore Medical Center, RealCME or Sanofi and Regeneron. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


PRIVACY STATEMENT
Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development (Einstein-Montefiore) protects the privacy of personal and other information regarding participants and education collaborators. Einstein-Montefiore will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting to the ACCME. Einstein-Montefiore maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information collected from you.


COLLECTION AND USE OF YOUR PERSONAL INFORMATION
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing an activity. Required items include first name, last name, middle initial, degree, email address, address and phone number. These items are necessary. Participants are also required to complete an evaluation of each activity. All evaluative information submitted is collected, retained, and used by Einstein-Montefiore to continuously improve the learning experience. Einstein-Montefiore will not transfer, sell, or share personal information with outside parties or otherwise disclose personal information unless required to in a legal process. Einstein-Montefiore will retain your personal data only for the period necessary to accomplish the stated purposes and to comply with applicable laws.


CONTACT INFORMATION
For questions regarding CME credit, contact Albert Einstein College of Medicine-Montefiore Medical Center at cme@montefiore.org.

For technical questions related to this activity, please contact support@gathered.com.